Robert Gordon
Psychiatry · Upland, CANPI 1528041654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,136 and has fallen 65.0% since, to $398 in 2022.
Across 215 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$568
- Sunovion Pharmaceuticals Inc.$512
- Otsuka America Pharmaceutical, Inc.$380
- Lundbeck LLC$359
- Vanda Pharmaceuticals Inc.$321
- AbbVie$189
- plus $978 from 16 others
What the payments were for
- Food & beverage$3,308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $568 |
| Sunovion Pharmaceuticals Inc. | 47 | $512 |
| Otsuka America Pharmaceutical, Inc. | 27 | $380 |
| Lundbeck LLC | 23 | $359 |
| Vanda Pharmaceuticals Inc. | 14 | $321 |
| AbbVie(2 entities) | 19 | $189 |
| Ironshore Pharmaceuticals Inc. | 6 | $164 |
| Bausch Health US, LLC | 7 | $146 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $124 |
| Adlon Therapeutics L.p. | 7 | $110 |
| Johnson & Johnson | 6 | $88 |
| Alkermes, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $43 |
| Merck | 2 | $43 |
| Eisai Inc. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Noven Therapeutics, LLC | 1 | $22 |
| Indivior Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$3,308 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Upland
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.